This Adacel market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.
Market growth during the historical period can be attributed to several factors, including an increase in the incidence of preventable diseases, higher vaccination rates among children, expanded maternal immunization, greater regulatory approvals, and enhanced public awareness.
Growth during the market's forecast period is expected to be driven by the rising prevalence of chronic diseases, higher vaccination rates, a growing population, increasing demand for healthcare, and more funding from both private and government organizations. Key trends for the forecast period include the integration of AI and other advanced technologies, technological advancements, the expansion of AI and automation, the adoption of speech recognition technology, and developments in cloud technologies.
The increasing trend in children's vaccination is expected to drive the growth of the adacel market. Children's vaccination involves administering vaccines to protect children from a range of infectious diseases. The growth in children's vaccination is driven by factors such as increased awareness, improved access to healthcare, government vaccination initiatives, and advancements in vaccine technology, all of which aim to prevent childhood diseases and enhance public health. Adacel is particularly beneficial in children's vaccination as it provides protection against three serious diseases - diphtheria, tetanus, and pertussis (whooping cough) - in a single shot, reducing the risk of these infections in young children. For example, in July 2024, the Pan American Health Organization reported that global childhood immunization coverage stagnated in 2023, resulting in 2.7 million more under-vaccinated children compared to pre-pandemic levels. As a result, the rising trend in children's vaccination is helping to drive the demand for adacel.
A significant trend in the adacel market is its expansion to include broader age indications, allowing the vaccine to reach a wider age demographic and thereby enhancing public health protection. Adacel provides essential protection against tetanus, diphtheria, and pertussis, which can be especially dangerous for older adults due to weakened immunity and increased risk of complications. By offering a booster shot, Adacel helps maintain immunity and reduces the risk of infection in these vulnerable groups. For instance, in January 2023, Sanofi Pasteur Limited received approval from the U.S. Food and Drug Administration (FDA) for the use of Adacel during the third trimester of pregnancy, providing protection for infants under two months of age against pertussis. This innovative use of the vaccine boosts its efficacy, increases accessibility, and enhances patient safety, supporting global efforts to prevent infectious diseases. Adacel, a Tdap vaccine, is specifically designed for active booster immunization against tetanus, diphtheria, and pertussis, targeting individuals aged 10 to 64 years.
In March 2024, Dr. Reddy's Laboratories, an India-based pharmaceutical company, formed a partnership with Sanofi Healthcare India Private Limited to improve access to Adacel across India. This collaboration aims to make the vaccine more widely available in both urban and rural healthcare settings. This is crucial for achieving widespread immunization, especially to prevent pertussis outbreaks in vulnerable populations such as infants and pregnant women. Sanofi Healthcare India Private Limited is a biopharmaceutical company in India specializing in vaccine development, including Adacel.
The key company operating in the adacel market is Sanofi Pasteur.
North America was the largest region in the adacel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in adacel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the adacel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Adacel is a vaccine that offers protection against tetanus, diphtheria, and pertussis (whooping cough). It is typically administered as a booster shot to individuals aged 10 and older. Adacel works by stimulating the immune system to produce antibodies against the toxins of tetanus, diphtheria, and pertussis without causing the actual disease. The vaccine uses inactivated toxins (toxoids) and purified antigens to promote long-lasting immunity.
The primary types of vaccines in the adacel market are Tdap vaccines and combination vaccines. Tdap vaccines are combination vaccines that protect against tetanus, diphtheria, and pertussis. Clinical indications for these vaccines include pertussis (whooping cough), diphtheria, and tetanus, with different age groups such as adults, geriatrics, and pediatrics being the target population. Distribution channels for Adacel vaccines include direct tenders, pharmacies, and online pharmacies, with end users including hospitals, clinics, and public health programs.
The adacel market research report is one of a series of new reports that provides adacel market statistics, including adacel industry global market size, regional shares, competitors with a adacel market share, detailed adacel market segments, market trends, and opportunities, and any further data you may need to thrive in the adacel industry. This adacel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The adacel market consists of sales of single-dose prefilled syringes and multi-dose vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Market growth during the historical period can be attributed to several factors, including an increase in the incidence of preventable diseases, higher vaccination rates among children, expanded maternal immunization, greater regulatory approvals, and enhanced public awareness.
Growth during the market's forecast period is expected to be driven by the rising prevalence of chronic diseases, higher vaccination rates, a growing population, increasing demand for healthcare, and more funding from both private and government organizations. Key trends for the forecast period include the integration of AI and other advanced technologies, technological advancements, the expansion of AI and automation, the adoption of speech recognition technology, and developments in cloud technologies.
The increasing trend in children's vaccination is expected to drive the growth of the adacel market. Children's vaccination involves administering vaccines to protect children from a range of infectious diseases. The growth in children's vaccination is driven by factors such as increased awareness, improved access to healthcare, government vaccination initiatives, and advancements in vaccine technology, all of which aim to prevent childhood diseases and enhance public health. Adacel is particularly beneficial in children's vaccination as it provides protection against three serious diseases - diphtheria, tetanus, and pertussis (whooping cough) - in a single shot, reducing the risk of these infections in young children. For example, in July 2024, the Pan American Health Organization reported that global childhood immunization coverage stagnated in 2023, resulting in 2.7 million more under-vaccinated children compared to pre-pandemic levels. As a result, the rising trend in children's vaccination is helping to drive the demand for adacel.
A significant trend in the adacel market is its expansion to include broader age indications, allowing the vaccine to reach a wider age demographic and thereby enhancing public health protection. Adacel provides essential protection against tetanus, diphtheria, and pertussis, which can be especially dangerous for older adults due to weakened immunity and increased risk of complications. By offering a booster shot, Adacel helps maintain immunity and reduces the risk of infection in these vulnerable groups. For instance, in January 2023, Sanofi Pasteur Limited received approval from the U.S. Food and Drug Administration (FDA) for the use of Adacel during the third trimester of pregnancy, providing protection for infants under two months of age against pertussis. This innovative use of the vaccine boosts its efficacy, increases accessibility, and enhances patient safety, supporting global efforts to prevent infectious diseases. Adacel, a Tdap vaccine, is specifically designed for active booster immunization against tetanus, diphtheria, and pertussis, targeting individuals aged 10 to 64 years.
In March 2024, Dr. Reddy's Laboratories, an India-based pharmaceutical company, formed a partnership with Sanofi Healthcare India Private Limited to improve access to Adacel across India. This collaboration aims to make the vaccine more widely available in both urban and rural healthcare settings. This is crucial for achieving widespread immunization, especially to prevent pertussis outbreaks in vulnerable populations such as infants and pregnant women. Sanofi Healthcare India Private Limited is a biopharmaceutical company in India specializing in vaccine development, including Adacel.
The key company operating in the adacel market is Sanofi Pasteur.
North America was the largest region in the adacel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in adacel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the adacel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Adacel is a vaccine that offers protection against tetanus, diphtheria, and pertussis (whooping cough). It is typically administered as a booster shot to individuals aged 10 and older. Adacel works by stimulating the immune system to produce antibodies against the toxins of tetanus, diphtheria, and pertussis without causing the actual disease. The vaccine uses inactivated toxins (toxoids) and purified antigens to promote long-lasting immunity.
The primary types of vaccines in the adacel market are Tdap vaccines and combination vaccines. Tdap vaccines are combination vaccines that protect against tetanus, diphtheria, and pertussis. Clinical indications for these vaccines include pertussis (whooping cough), diphtheria, and tetanus, with different age groups such as adults, geriatrics, and pediatrics being the target population. Distribution channels for Adacel vaccines include direct tenders, pharmacies, and online pharmacies, with end users including hospitals, clinics, and public health programs.
The adacel market research report is one of a series of new reports that provides adacel market statistics, including adacel industry global market size, regional shares, competitors with a adacel market share, detailed adacel market segments, market trends, and opportunities, and any further data you may need to thrive in the adacel industry. This adacel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The adacel market consists of sales of single-dose prefilled syringes and multi-dose vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Adacel Market Characteristics4. Adacel Market Trends and Strategies5. Adacel Market -Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market7. Global Adacel Pricing Analysis & Forecasts30. Global Adacel Market Competitive Benchmarking and Dashboard31. Key Mergers and Acquisitions in the Adacel Market32. Recent Developments in the Adacel Market
3. Adacel Market Biologic Drug Characteristics
6. Global Adacel Growth Analysis and Strategic Analysis Framework
8. Adacel Market Segmentation
9. Global Adacel Epidemiology of Clinical Indications
10. Adacel Market Regional and Country Analysis
11. Asia-Pacific Adacel Market
12. China Adacel Market
13. India Adacel Market
14. Japan Adacel Market
15. Australia Adacel Market
16. South Korea Adacel Market
17. Western Europe Adacel Market
18. UK Adacel Market
19. Germany Adacel Market
20. France Adacel Market
21. Eastern Europe Adacel Market
22. North America Adacel Market
23. USA Adacel Market
24. Canada Adacel Market
25. South America Adacel Market
26. Middle East Adacel Market
27. Africa Adacel Market
28. Adacel Market Competitive Landscape and Company Profiles
29. Global Adacel Market Pipeline Analysis
33. Adacel Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Adacel Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on adacel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for adacel? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adacel market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Vaccine Type: Tdap Vaccines; Combination Vaccines2) by Clinical Indication: Pertussis (Whooping Cough); Diphtheria; Tetanus
3) by Age Group: Adult; Geriatric; Pediatric
4) by Distribution Channel: Direct Tenders; Pharmacies; Online Pharmacies
5) by End User: Hospitals; Clinics; Public Health Programs
Key Companies Mentioned: Sanofi Pasteur
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Sanofi Pasteur
